**Core tip:** In this study, we found that HOX transcript antisense intergenic RNA (HOTAIR) expression was up-regulated in gastric cancer (GC) tissues. High expression of HOTAIR was associated with clinicopathological characteristics and poor prognosis in GC patients. Additional experiments revealed that HOTAIR knockdown significantly inhibited the invasion and migration of GC cells. We also tested whether HOTAIR recruited EZH2 to promote tumor cell migration and invasion by repressing E-cadherin in GC. The findings from our study will help clarify the role of HOTAIR in GC progression and its potential as a therapeutic target.

INTRODUCTION
============

Gastric cancer (GC) is one of the most common malignancies worldwide, having high rates of both incidence and mortality\[[@B1]\]. Even though remarkable progress has been made in surgical resection and chemotherapy, which are the main therapeutic approaches for GC, the prognosis continues to be dismal\[[@B2]\]. The main cause of treatment failure is cancer recurrence and metastasis\[[@B3],[@B4]\].

Tumor metastasis is a complex process, in which cancer cells leave the primary tumor site and migrate to distant secondary organs. Metastatic cancer cells fractionally retain their epithelial properties and obtain mesenchymal characteristics that give them the ability to invade or distract\[[@B5]\]. This process is called epithelial-to-mesenchymal transition (EMT). EMT is characterized by E-cadherin expression loss and N-cadherin and vimentin up-regulation\[[@B6]\]. It is regulated by many signaling pathways, transcriptional factors and post-transcriptional factors\[[@B7]\]. Post-transcriptional regulatory networks include the miRNA and long noncoding (lnc)RNA families\[[@B8]\]. Emerging evidence shows that lncRNAs have an important role in regulating EMT and cancer metastasis\[[@B5],[@B9]\]. Several important lncRNAs are reported to induce EMT, including highly upregulated in liver cancer (HULC)\[[@B10]\], metastasis-associated lung adenocarcinoma transcript (MALAT)-1\[[@B11]\], H19\[[@B12]\], and HOX transcript antisense intergenic RNA (HOTAIR)\[[@B13]\].

HOTAIR is identified as an oncogene involved in many kinds of cancers, including breast cancer\[[@B14]\], esophageal squamous cell carcinoma\[[@B15]\], colorectal cancer\[[@B16]\], and GC\[[@B13]\]. HOTAIR acts mainly through the polycomb repressive complex (PRC)2 (EZH2, RbAp46, RbAp48 and SUZ12)\[[@B17]\], which trimethylates histone H3 lysine-27 (H3K27) of the HOXD locus and repress HOXD gene expression\[[@B14]\]. EZH2 which is the core catalytic component of the PRC2, can affect cancer progression by altering H3K27 trimethylation and silencing transcription\[[@B17]\].

A previous study showed that silencing of HOTAIR inhibits GC cell migration, invasion and metastasis, and reverses the EMT in GC cells\[[@B13]\]. HOTAIR in combination with PRC2 could epigenetically inhibit miR34a, and control C-Met (HGF/C-Met/Snail pathway) and Snail, thus promoting the EMT process of GC cells and tumor metastasis\[[@B13]\]. However, the overall clinical role of HOTAIR in GC and the molecular mechanisms of HOTAIR involved in GC cell metastasis have not yet been fully investigated.

Up-regulation of HOTAIR expression in GC tissues was found in the present study. We also found that over-expression of HOTAIR was related to the clinicopathological characteristics of and poor prognosis in GC patients. Additional experiments revealed that HOTAIR knockdown significantly repressed migration and invasion. Finally, we tested whether HOTAIR recruited EZH2 to promote tumor cell migration and invasion by repressing E-cadherin in GC. These studies will help clarify the role of HOTAIR in GC progression and its potential as a therapeutic target.

MATERIALS AND METHODS
=====================

Tissue collection and ethics statement
--------------------------------------

A cohort of 65 primary GC patients was enrolled in this study, each of who underwent surgery at the First Affiliated Hospital of Nanjing Medical University and Jining NO.1 People's Hospital between 2008 and 2009. None received chemotherapy or radiotherapy prior to surgery. This study was approved by the University Ethics Committee. All patients participated after providing informed consent. Tumor stage was evaluated in accordance with the tumor-node-metastasis (TNM) classification system (UICC/AJCC 2002). Clinical characteristics are shown in Table [1](#T1){ref-type="table"}. Patients discharged from hospital were followed up routinely and according to a scheduled program, at least once a year.

###### 

Relationships between the expression of HOTAIR and clinicopathological characteristics in 65 patients with gastric cancer

  **Characteristic**         **Expression of HOTAIR**   ***P* value**   
  -------------------------- -------------------------- --------------- --
  Sex                        0.408                                      
  Female                     7                          11              
  Male                       25                         22              
  Age in yr                  0.455                                      
  ≤ 60                       17                         21              
  \> 60                      15                         12              
  Histological grade         1.000                                      
  Well/moderate              14                         15              
  Other                      18                         18              
  Tumor invasion depth, T    0.018                                      
  Tis, T1,T2                 15                         6               
  T3 or above                17                         27              
  Lymph node metastasis, N   0.023                                      
  N0                         12                         4               
  N1 or above                20                         29              
  TNM stage                  0.024                                      
  I/II                       23                         14              
  III/IV                     9                          19              
  Tumor location             0.102                                      
  Antrum                     8                          15              
  Cardia                     10                         9               
  Angulus                    13                         5               
  Body                       1                          3               
  Full stomach               0                          1               
  Laure's classification     0.373                                      
  Intestinal                 17                         15              
  Diffuse                    12                         17              
  Mixed                      3                          1               

Cell lines and culture conditions
---------------------------------

Human GC cell lines SGC-7901and BGC-823 were obtained from the Chinese Academy of Sciences Committee on Type Culture Collection Cell Bank. Cells were cultured in RPMI 1640 or Dulbecco's modified Eagle's medium (Gibco-BRL, Shanghai, China) supplemented with 10% fetal bovine serum (FBS) (Invitrogen, Shanghai, China), 100 U/mL penicillin, and 100 mg/mL streptomycin (Invitrogen) in an incubator at 37 °C with 5% CO~2~.

RNA extraction and quantitative polymerase chain reaction (qPCR)
----------------------------------------------------------------

Total RNA was extracted from the frozen tissues using TRIzol reagent (Invitrogen). RNA concentrations were estimated by spectrophotometer absorbance readings of 260 nm. One microgram of total RNA was used for reverse transcription to cDNA with a Reverse Transcription Kit (TaKaRa, Shiga, Japan). An ABI 7500 real-time PCR system (Applied Biosystems, Foster City, CA, United States) was used to quantify HOTAIR. Ten microliters of SYBR Premix Ex*Taq* (TaKaRa) was mixed. Primer sequences are listed in Supplementary Table [1](#T1){ref-type="table"}. The relative expression was calculated using the equation: ΔCt = Ct (target gene) -- Ct (GAPDH); Fold change = 2^--\[ΔCt(tumour)\ --\ ΔCt(nomal)\]\[18\]^.

Cell transfection
-----------------

HOTAIR small interfering (si)RNAs and negative control siRNA (si-NC) were purchased from Invitrogen. The siRNA sequences are listed in Supplementary Table [1](#T1){ref-type="table"}. BGC-823 or SGC-7901 cells were grown in 6-well plates until confluent, then transfected with Lipofectamine 2000 (Invitrogen). At 48 h after transfection, cells were harvested for qPCR or western blot analysis.

Wound-healing assay
-------------------

Cells were seeded in 6-well plates in normal cell growth medium and incubated to confluence. A 20-μL tip was used to make a straight scratch, simulating a wound. The medium was changed to medium containing 1% FBS. At different time points, images of the plates were acquired using a microscope.

Cell migration and invasion assays
----------------------------------

For the migration assays, at 48 h after transfection, 5 × 10^4^ cells in serum-free medium were placed into the upper chamber of an insert (8-μm pore size; Millipore, Bedford, MA, United States). For the invasion assays, 10^5^ cells in serum-free medium were placed into the upper chamber of an insert coated with Matrigel (Sigma-Aldrich, St. Louis, MO, United States). Medium containing 10% FBS was added to the lower chamber. After incubation for 24 h, the cells remaining on the upper membrane were removed with cotton wool. Cells that had migrated or invaded through the membrane were stained with methanol and 0.1% crystal violet, imaged and counted in five random fields per well using an IX71 inverted microscope (Olympus, Tokyo, Japan). Experiments were repeated independently three times.

Western blot assay and antibodies
---------------------------------

Cell protein lysates were separated by 15% SDS-PAGE, transferred to 0.22-μm nitrocellulose membranes (Sigma-Aldrich) and incubated with specific antibodies. GAPDH antibody was used as a control. Autoradiograms were quantified by densitometry (Quantity One software; Bio-Rad, Hercules, CA, United States). Anti-E-cadherin was purchased from Abcam (Cambridge, United Kingdom). Anti-GAPDH was purchased from Cell Signaling Technology (Danvers, MA, United States).

RNA-binding protein immunoprecipitation assay
---------------------------------------------

Binding protein immunoprecipitation assay (RIP) experiments were performed using a Magna RIP RNA-Binding Protein Immunoprecipitation Kit (Millipore). Antibody for EZH2 RIP assays was from Abcam.

Chromatin immunoprecipitation assay
-----------------------------------

Chromatin immunoprecipitation assay (ChIP) assays were performed using an EZ-CHIP KIT (Millipore). EZH2 antibody was obtained from Abcam. H3 trimethyl Lys 27 antibody was from Millipore. The ChIP primer sequences are listed in Supplementary Table [1](#T1){ref-type="table"}. Quantification of immunoprecipitated DNA was performed using qPCR with SYBR Green Mix (TaKaRa). ChIP data were calculated as a percentage relative to the input DNA by the equation of 2^(Input\ Ct\ -\ Target\ Ct)^ × 0.1 × 100.

Immunohistochemistry
--------------------

The immunohistochemical analysis of E-cadherin was performed as described previously\[[@B19]\]. To quantify E-cadherin protein expression, both the intensity and extent of immunoreactivity were evaluated and scored. In the present study, staining intensity was scored as follows: 0, negative staining; 1, weak staining; 2, moderate staining; and 3, strong staining. The scores of the extent of immunoreactivity ranged from 0 to 3, and were determined according to the percentage of cells that showed positive staining in each microscopic field of view (0, \< 25%; 1, 25%-50%; 2, 50%-75%; 3, 75%-100%). A final score ranging from 0 to 9 was achieved by multiplying the scores for intensity and extent.

Statistical analysis
--------------------

SPSS version 21.0 software was used for all statistical analysis. Significance of the differences between groups was estimated by Student's *t*-test, χ*^2^* test, or Mann-Whitney test. Survival curves were estimated by the Kaplan-Meier method. The log-rank test was used to estimate the statistical difference between survival curves. Cox proportional hazards analysis was performed to calculate the hazard ratio (HR) and the 95% confidence interval (CI) to evaluate the association between HOTAIR expression and overall survival (OS) time. Multivariate Cox regression was performed to adjust for other covariates. Spearman correlation analysis was performed to investigate the correlation between HOTAIR and E-cadherin mRNA expression. Receiver operating characteristic (ROC) curve was produced to evaluate the diagnostic value for differentiating between GC and adjacent non-tumor tissues. A two-tailed *P* value of ≤ 0.05 was considered statistically significant. All the graphs were plotted using GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA, United States).

RESULTS
=======

HOTAIR was up-regulated in GC tissues
-------------------------------------

HOTAIR showed markedly higher expression in GC tissues as compared with matched adjacent non-tumor tissues (*P* \< 0.001; Figure [1A](#F1){ref-type="fig"}).

![HOTAIR up-regulation correlates with poor survival in patients with GC. A: HOTAIR expression was significantly up-regulated in tumor tissues compared with their corresponding para-carcinoma tissues (shown as -ΔCt); B: ROC curves for observing the diagnostic value of HOTAIR; C: HOTAIR expression was classified into two groups according to HOTAIR expression levels (median split); D: Kaplan-Meier analysis of OS was analyzed according to HOTAIR expression levels; E: Different factors (including HOTAIR, tumor invasion depth, lymph node metastasis, TNM stage, histological grade, gender, tumor location, Lauren's classification and age) were analyzed for their association with patient survival using Cox regression model. The hazard ratio and 95%CI are plotted for each factor. CI: Confidence interval; GC: Gastric cancer; HOTAIR: HOX transcript antisense intergenic RNA; OS: Overall survival; ROC: Receiver operating characteristic; TNM: Tumor-node-metastasis.](WJG-23-6100-g001){#F1}

Diagnostic value of using HOTAIR as a marker
--------------------------------------------

An ROC curve was generated by comparing HOTAIR expression in GC tissues to expression in matched adjacent non-tumor tissues. With a cut-off value of 9.31, the area under the ROC curve (AUC~ROC~) reached 0.709 (95%CI: 0.623-0.785, *P* \< 0.001; Figure [1B](#F1){ref-type="fig"}). The sensitivity was 64.62%, the specificity was 75.38%, and Youden\'s index was 0.4.

HOTAIR expression and clinicopathological factors in GC
-------------------------------------------------------

Patients with GC were divided into two groups based on the cut-off ratio of HOTAIR expression (2.35-fold) in tumor tissues: high-expression group (*n* = 33) and low-expression group (*n* = 32) (Figure [1C](#F1){ref-type="fig"}). Table [1](#T1){ref-type="table"} showed that HOTAIR over-expression was significantly correlated with tumor invasion (*P* = 0.018), lymph node metastasis (*P* = 0.023) and higher TNM stage (*P* = 0.024). However, there was no correlation between HOTAIR expression and age, sex and histological grade (*P* \> 0.05).

Up-regulation of HOTAIR associated with poor survival of GC
-----------------------------------------------------------

To assess the impact of HOTAIR expression on OS of GC patients, Kaplan-Meier analysis and log rank test were used. The results revealed that patients in the high-expression group had a shorter OS (median OS: 25.9 mo) than those in the low-expression group (median OS: 42.5 mo, *P* \< 0.001; Figure [1D](#F1){ref-type="fig"}). Univariate analyses of clinical variables considered as potential predictors of survival are shown in Table [2](#T2){ref-type="table"}. Further analysis in a multivariate Cox proportional hazards model showed that HOTAIR expression (*P* = 0.033), along with TNM stage (*P* = 0.002) and lymph node metastasis (*P* = 0.002), were strongly associated with OS. These results revealed that HOTAIR expression was an independent prognostic indicator of OS.

###### 

Univariate and multivariate analysis of clinical pathological characteristics and overall survival of 65 patients with gastric cancer

  **Factor**                               **Univariate analysis**   **Multivariate analysis**                                     
  ---------------------------------------- ------------------------- --------------------------- ---------- ------- -------------- -------
  HOTAIR expression                        2.943                     1.580-5.483                 0.001      1.998   1.058-3.772    0.033
  Tumor invasion depth, T1, T2/above       2.651                     1.316-5.341                 0.006      1.676   0.691-4.067    0.254
  Lymphatic metastasis, absent/present     3.470                     1.459-8.250                 0.005      4.324   1.701-10.993   0.002
  TNM stage, I/II, III/IV                  4.494                     2.351-8.592                 \< 0.001   3.598   1.624-7.975    0.002
  Histology grade, well, moderate/others   0.967                     0.535-1.750                 0.913                             
  Age, \< 60/\> 60                         0.730                     0.396-1.344                 0.312                             
  Sex, male/female                         0.822                     0.428-1.581                 0.557                             
  Tumor location                           0.839                     0.623-1.131                 0.250                             
  Lauren's classification                  1.256                     0.757-2.084                 0.378                             

Knockdown of HOTAIR suppressed migration and invasion of GC cells
-----------------------------------------------------------------

The wound-healing assay showed that HOTAIR knockdown cells were significantly slower than control cells (Figure [2A](#F2){ref-type="fig"}-D). Transwell assay and invasion assay demonstrated knockdown of HOTAIR notably reduced the number of BGC-823 or SGC-7901 cells migrating across the membrane (Figure [2E](#F2){ref-type="fig"}-H). These results confirmed that knockdown of HOTAIR inhibited the migration and invasion of GC cells.

![HOTAIR knockdown decreases migration and invasion of gastric cancerGC cells. A and B: HOTAIR knockdown samples exhibited slower scratch closure rate by the wound-healing detection in BGC-823 cells; C and B: Wound-healing assay in SGC-7901 cells with HOTAIR silencing; E and F: Representative pictures of cell migration across the membrane in BGC-823 and SGC-7901 cells with HOTAIR reduction; G and H: Representative pictures of Transwell invasion assay in BGC-823 and SGC-7901 cells with HOTAIR depletion. (^a^*P* \< 0.05, ^b^*P* \< 0.01). GC: Gastric cancer; HOTAIR: HOX transcript antisense intergenic RNA.](WJG-23-6100-g002){#F2}

HOTAIR was inversely correlated with E-cadherin in GC tissue and cell lines
---------------------------------------------------------------------------

The HOTAIR and E-cadherin expression levels in GC tissues were detected by qPCR and immunohistochemistry. E-cadherin expression was significantly down-regulated in tumor tissues (*P* = 0.001), as compared with the para-tumorous tissues (Figure [3A](#F3){ref-type="fig"} and B). E-cadherin mRNA levels were negatively associated with HOTAIR expression in GC tissues (*r*^2^ = -0.298, *P* = 0.016) (Figure [3C](#F3){ref-type="fig"}). HOTAIR silencing strikingly enhanced the expression of E-cadherin at transcript (Figure [3D](#F3){ref-type="fig"} and E) and protein (Figure [3F](#F3){ref-type="fig"} and G) levels in BGC-823 and SGC-7901 cells. These results demonstrated that HOTAIR promoted EMT in GC tissues and cell lines, and that HOTAIR over-expression was significantly associated with migration and invasion.

![HOTAIR negatively correlates to E-cadherin expression in GC tissues and cell lines. A: E-cadherin immunostaining in para-carcinoma tissues (denoted as '*P*') and GC tissues (denoted as 'T'); B: Representative E-cadherin protein levels and scores in GC tissues and para-carcinoma tissues was analyzed by immunohistochemistry (*n* = 30); C: Negative correlation between E-cadherin mRNA levels and HOTAIR levels in 65 GC samples; D, E: Relative expression of HOTAIR and E-cadherin in BGC-823 and SGC-7901 cells treated with siRNA for 48 h; F, G: Western blot analysis of E-cadherin after HOTAIR-siRNA (Si1 and Si2) treatment for 48 h in BGC-823 and SGC-7901 cells. ^a^*P* \< 0.05, ^b^*P* \< 0.01. GC: Gastric cancer; HOTAIR: HOX transcript antisense intergenic RNA; si: Small interfering.](WJG-23-6100-g003){#F3}

HOTAIR recruited EZH2 to inhibit the expression of E-cadherin
-------------------------------------------------------------

HOTAIR plays its role in the epigenetic regulation of gene expression mainly by binding to PRC2 complex. We firstly used RIP assay to investigate whether HOTAIR could bind to EZH2, which is the core catalytic component of the PRC2. The results showed that endogenous HOTAIR was abundant in the anti-EZH2 RIP fraction (Figure [4A](#F4){ref-type="fig"}), validating that HOTAIR can bind to EZH2 in GC cells. Then we conducted ChIP assay to determine whether HOTAIR regulates E-adherin *via* recruiting EZH2 in GC cell lines. ChIP assay demonstrated that knockdown of HOTAIR significantly reduced the binding of EZH2 and H3K27me3 with the E-cadherin promoter in GC cells (Figure [4B](#F4){ref-type="fig"}). The rescue experiments showed that up-regulation of HOTAIR increased the binding of EZH2 and H3K27me3 with the E-cadherin promoter in GC cells (Figure [4C](#F4){ref-type="fig"}). These results indicated that HOTAIR inhibits E-cadherin expression partly through combining with EZH2.

![HOTAIR represses E-cadherin expression by associating with EZH2. A: RIP experiments were performed in BGC-823 and SGC-7901 cells, and HOTAIR levels were analyzed in co-precipitated RNA using qPCR. The fold-enrichment of HOTAIR in EZH2 RIP is relative to its matching IgG control RIP (*^a^P* \< 0.05, *^b^P* \< 0.01); B: ChIP of EZH2 and H3K27me3 in the E-cadherin promoter regions after siRNA treatment targeting si-NC or HOTAIR-siRNA-1 in BGC-823 and SGC-7901 cells. qPCR was performed to quantify ChIP assay results. Enrichment was quantified relative to input controls. Antibody directed against IgG was used as a negative control. Results are represented as the average ± SD based on three independent experiments. ^a^*P* \< 0.05, ^b^*P* \< 0.01; C: ChIP of EZH2 and H3K27me3 in the E-cadherin promoter regions after transfected with empty vector (denoted as 'pcDNA') or pcDNA-HOTAIR in BGC-823 and SGC-7901 cells. qPCR was performed to quantify ChIP assay results. Enrichment was quantified relative to input controls. Results are represented as the average ± SD based on three independent experiments (^a^*P* \< 0.05, ^b^*P* \< 0.01). ChIP: Chromatin immunoprecipitation; GC: Gastric cancer; HOTAIR: HOX transcript antisense intergenic RNA; qPCR: Quantitative polymerase chain reaction; RIP: RNA-binding protein immunoprecipitation; SD: Standard deviation; si: Small interfering.](WJG-23-6100-g004){#F4}

DISCUSSION
==========

LncRNAs are non-protein-coding transcripts \> 200 nucleotides. Dysregulation of lncRNAs has been found in GC cells and their aberrant expression is correlated with tumorigenesis, metastasis, prognosis or diagnosis\[[@B20],[@B21]\].

We found that HOTAIR was markedly up-regulated in GC tissues, which was correlated with the invasion of primary tumor, lymph node metastasis, and TNM stage. The ROC curve used for distinguishing between GC tissues and normal tissues showed that HOTAIR is a promising cancer biomarker. Univariate and multivariate Cox regression analyses demonstrated that HOTAIR is a valuable prognostic factor independent of major clinicopathological features. We also found that decreased HOTAIR expression inhibited migration and invasion of tumor cells.

To clarify the molecular mechanism of HOTAIR action contributing to GC metastasis, we also investigated potential target genes involved in cell migration and invasion. Previous studies have revealed that the expression of epithelial markers (such as E-cadherin) are increased following HOTAIR knockdown in GC cells\[[@B13],[@B22],[@B23]\]. Further mechanistic studies have shown that by recruiting and binding to PRC2, HOTAIR could epigenetically silence miR34a expression to promote GC cell EMT and metastasis\[[@B13]\]. However, there are still some issues that need to be clarified. For one thing, E-cadherin is a target gene of EZH2. Because EZH2 can mediate transcriptional silencing of E-cadherin through trimethylation of H3 lysine 27\[[@B24],[@B25]\], and HOTAIR binds to EZH2\[[@B14]\]. Furthermore, a significantly negative correlation was found between HOTAIR and E-cadherin in GC tissues in the present study, and knockdown of EZH2 also up-regulated E-cadherin expression in GC cells as shown by another study\[[@B26]\]. So, why does HOTAIR not regulate expression of E-cadherin directly by binding to EZH2? We speculate that HOTAIR promotes tumor cell migration and invasion by repressing E-cadherin *via* EZH2 directly. To confirm this, we performed ChIP analysis in HOTAIR-silenced GC cell lines. Not unexpectedly, HOTAIR contributed to the regulation of E-cadherin *via* recruiting EZH2 and H3K27me3 to the E-cadherin promoter. Our findings provide additional insight into the mechanisms by which HOTAIR promotes GC migration and invasion.

In conclusion, we demonstrated that HOTAIR was significantly up-regulated in GC tissues, and its overexpression was correlated with tumor progression and poor prognosis. We can distinguish between cancerous and non-cancerous lesions based on the expression of HOTAIR. HOTAIR may regulate the invasive ability of GC cells, partially *via* EMT regulation. Our findings have provided new insight into the GC pathogenesis, which benefits diagnosis and therapy in cancer.

COMMENTS
========

Background
----------

Gastric cancer (GC) is one of the most aggressive malignancies with high morbidity and mortality worldwide. Treatment options are limited due to the lack of knowledge of the molecular and genetic bases of gastric carcinogenesis. A deeper understanding of the molecular mechanisms of GC will shed light on its pathogenesis, and identification of new biomarkers for diagnosis and prognosis may improve individualized treatment strategies in the future.

Research frontiers
------------------

Emerging evidence suggest that long non-coding (lnc)RNA may play a role in gastric carcinogenesis. HOX transcript antisense intergenic RNA (HOTAIR) is one of the well-documented lncRNAs, which is aberrantly expressed in several tumors and plays a crucial role in cancer development. However, the overall clinical role of HOTAIR in GC and the molecular mechanisms of HOTAIR involved in GC cell metastasis has not yet been well investigated.

Innovations and breakthrough
----------------------------

The authors demonstrated that HOTAIR promotes tumor cell migration and invasion by repressing E-cadherin *via* EZH2 directly. Their findings have provided additional insight into the mechanisms of gastric carcinogenesis.

Applications
------------

The results from this study provide novel clues for further investigation of HOTAIR as a potential biomarker and therapeutic target for GC.

Terminology
-----------

RNA-binding protein immunoprecipitation assay was used for the analysis of EZH2 interactions with HOTAIR. ChIP assay was performed to investigate direct interactions between EZH2 and E-cadherin.

Peer-review
-----------

The study aimed to investigate the clinical significance and the mechanism behind lncRNA HOTAIR in GC. The overall study is solid and well designed. The results are consistent with the proposed hypothesis.
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